论文部分内容阅读
Objective Bisphosphonates are commonly administered as bone-specific anti-resorptive agents to patients who at increased risk of developing osteoporosis,multiple myeloma(MM),Pagets disease,and bone metastases.Medication-related osteonecrosis of the jaw(MRONJ)is a severe complication that can develop within patients treated with antiresorptive drugs.